Journal of Vascular Surgery
Volume 48, Issue 3 , Pages 519-526 , September 2008

A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair

  • Amy E. Hackmann, MD

      Affiliations

    • Department of Surgery (Section of Vascular Surgery), Washington University School of Medicine, St. Louis, Mo
  • ,
  • Brian G. Rubin, MD

      Affiliations

    • Department of Surgery (Section of Vascular Surgery), Washington University School of Medicine, St. Louis, Mo
    • Department of Radiology, Washington University School of Medicine, St. Louis, Mo
  • ,
  • Luis A. Sanchez, MD

      Affiliations

    • Department of Surgery (Section of Vascular Surgery), Washington University School of Medicine, St. Louis, Mo
    • Department of Radiology, Washington University School of Medicine, St. Louis, Mo
  • ,
  • Patrick A. Geraghty, MD

      Affiliations

    • Department of Surgery (Section of Vascular Surgery), Washington University School of Medicine, St. Louis, Mo
    • Department of Radiology, Washington University School of Medicine, St. Louis, Mo
  • ,
  • Robert W. Thompson, MD

      Affiliations

    • Department of Surgery (Section of Vascular Surgery), Washington University School of Medicine, St. Louis, Mo
    • Department of Radiology, Washington University School of Medicine, St. Louis, Mo
    • Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Mo
  • ,
  • John A. Curci, MD

      Affiliations

    • Department of Surgery (Section of Vascular Surgery), Washington University School of Medicine, St. Louis, Mo
    • Corresponding Author InformationCorrespondence: John A. Curci, MD, Department of Surgery, Section of Vascular Surgery, Washington University in Saint Louis, 660 S Euclid Ave, Campus Box 8109, Saint Louis, MO 63110

Received 19 December 2007 ,Accepted 31 March 2008.

References 

  1. Boyle JR, McDermott E, Crowther M, Wills AD, Bell PR, Thompson MM. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg. 1998;27:354–361
  2. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg. 1996;23:336–346
  3. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000;105:1641–1649
  4. Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg. 2000;31:325–342
  5. Baxter BT, Pearce WH, Waltke EA, Littooy FN, Hallett JW, Kent KC, et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg. 2002;36:1–12
  6. McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg. 1999;29:122–127discussion 127-9
  7. Rohde LE, Arroyo LH, Rifai N, Creager MA, Libby P, Ridker PM, et al. Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscl Thromb Vasc Biol. 1999;19:1695–1699
  8. Lorelli DR, Jean-Claude JM, Fox CJ, Clyne J, Cambria RA, Seabrook GR, et al. Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak. J Vasc Surg. 2002;35:916–922
  9. Fairman RM, Nolte L, Snyder SA, Chuter TA, Greenberg RK. Factors predictive of early or late aneurysm sac size change following endovascular repair. J Vasc Surg. 2006;43:649–656
  10. Wolf YG, Hill BB, Rubin GD, Fogarty TJ, Zarins CK. Rate of change in abdominal aortic aneurysm diameter after endovascular repair. J Vasc Surg. 2000;32:108–115
  11. Greenberg RK, Deaton D, Sullivan T, Walker E, Lyden SP, Srivastava SD, et al. Variable sac behavior after endovascular repair of abdominal aortic aneurysm: analysis of core laboratory data. J Vasc Surg. 2004;39:95–101
  12. Matsumura JS, Chaikof EL. Continued expansion of aortic necks after endovascular repair of abdominal aortic aneurysms (EVT Investigators. EndoVascular Technologies, Inc). J Vasc Surg. 1998;28:422–430discussion 430-1
  13. Conners MS, Sternbergh WC, Carter G, Tonnessen BH, Yoselevitz M, Money SR. Endograft migration one to four years after endovascular abdominal aortic aneurysm repair with the AneuRx device: a cautionary note. J Vasc Surg. 2002;36:476–484
  14. Hobo R, Buth J. Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts (A EUROSTAR report). J Vasc Surg. 2006;43:896–96
  15. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995;96:318–326
  16. Sangiorgi G, D'Averio R, Mauriello A, Bondio M, Pontillo M, Castelvecchio S, et al. Plasma levels of metalloproteinases-3 and −9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation. 2001;104(12 Suppl 1):I288–I295
  17. Thompson RW, Liao S, Curci JA. Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms. Adv Dent Res. 1998;12:159–165
  18. Crout RJ, Lee HM, Schroeder K, Crout H, Ramamurthy NS, Wiener M, et al. The “cyclic” regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol. 1996;67:506–514
  19. Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997;46:310–319
  20. McMillan WD, Tamarina NA, Cipollone M, Johnson DA, Parker MA, Pearce WH. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation. 1997;96:2228–2232
  21. Gerasimidis T, Sfyroeras G, Trellopoulos G, Skoura L, Papazoglou K, Konstantinidis K, et al. Impact of endograft material on the inflammatory response after elective endovascular abdominal aortic aneurysm repair. Angiology. 2005;56:743–753
  22. Tonnessen BH, Sternbergh III WC, Money SR. Mid- and long-term device migration after endovascular abdominal aortic aneurysm repair: a comparison of AneuRx and Zenith endografts. J Vasc Surg. 2005;42:392–401
  23. Sonesson B, Resch T, Lanne T, Ivancev K. The fate of the infrarenal aortic neck after open aneurysm surgery. J Vasc Surg. 1998;28:889–894
  24. Litwinski RA, Donayre CE, Chow SL, Song TK, Kopchok G, Walot I, et al. The role of aortic neck dilation and elongation in the etiology of stent graft migration after endovascular abdominal aortic aneurysm repair with a passive fixation device. J Vasc Surg. 2006;44:1176–1181
  25. Haider S-e-a, Najjar SF, Cho J-S, Rhee RY, Eskandari MK, Matsumura JS, et al. Sac behavior after aneurysm treatment with the Gore Excluder low-permeability aortic endoprosthesis: 12-month comparison to the original Excluder device. J Vasc Surg. 2006;44:694–700
  26. Ouriel K, Clair DG, Greenberg RK, Lyden SP, O'Hara PJ, Sarac TP, et al. Endovascular repair of abdominal aortic aneurysms: device-specific outcome. J Vasc Surg. 2003;37:991–998

 Supported by grants from the Barnes-Jewish Hospital Foundation (J.A.C.), National Institutes for Health (5K08HL084004-02, J.A.C.), Department of Veteran's Affairs (J.A.C.), Flight Attendants Medical Research Institute (J.A.C.), and the American Heart Association (0765432Z, J.A.C.).

 Competition of interest: Dr Geraghty has received consulting fees from W. L. Gore and Associates. Dr Sanchez has received consulting fees from W. L. Gore and Associates, Cook, and Medtronic.

PII: S0741-5214(08)00666-6

doi: 10.1016/j.jvs.2008.03.064

Journal of Vascular Surgery
Volume 48, Issue 3 , Pages 519-526 , September 2008